Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gerstoft

Showing results (151-160 of 198) with videos related to

Pageof 20
Sort By:
HIV Medicine|September 15, 2005
The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1,250 mg twice-daily regimen in HIV-infected patientsU S Justesen, I M Hansen, A B Andersen, et al.
Acta Medica Scandinavica|January 1, 1986
Prognosis in glomerulonephritis. II. Regression analyses of prognostic factors affecting the course of renal function and the mortality in 395 patients. Calculation of a prognostic model. Report from a Copenhagen study group of renal diseasesJ Gerstoft, J T Balsløv, M Brahm, et al.
Acta Medica Scandinavica|January 1, 1985
Prognosis in glomerulonephritis. A follow-up study of 395 consecutive, biopsy-verified cases. I. Classification, renal histology and outcome. Report from a Copenhagen study group of renal diseasesM Brahm, J T Balsløv, C Brun, et al.
Scandinavian Journal of Immunology|August 10, 2000
Effects of G-CSF on telomere lengths in PBMCs from human immunodeficiency virus-infected patients: results from a randomized, placebo-controlled trialH Aladdin, H Ullum, P Schjerling, et al.
AIDS (London, England)|November 1, 1990
Trends in survival of Danish AIDS patients from 1981 to 1989C Pedersen, J Gerstoft, P Tauris, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1989
Prognostic value of immunologic abnormalities and HIV antigenemia in asymptomatic HIV-infected individuals: proposal of immunologic stagingB Hofmann, I Bygbjerg, E Dickmeiss, et al.
HIV Medicine|August 9, 2011
Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV-infected individuals from 1995 to 2007: a nationwide cohort study*M V Larsen, Z B Harboe, S Ladelund, et al.
Scandinavian Journal of Immunology|September 6, 2000
The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individualsS D Nielsen, T U Sørensen, H Aladdin, et al.
European Journal of Clinical Investigation|August 1, 1984
T lymphocyte subsets in homosexual men from CopenhagenJ Gerstoft, C S Petersen, S Kroon, et al.
AIDS (London, England)|July 1, 1996
Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study GroupP Hermans, J Lundgren, B Sommereijns, et al.
Pageof 20

Showing results (151-160 of 198) with videos related to

Sort By:
Pageof 20
HIV Medicine|September 15, 2005
The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1,250 mg twice-daily regimen in HIV-infected patientsU S Justesen, I M Hansen, A B Andersen, et al.
Acta Medica Scandinavica|January 1, 1986
Prognosis in glomerulonephritis. II. Regression analyses of prognostic factors affecting the course of renal function and the mortality in 395 patients. Calculation of a prognostic model. Report from a Copenhagen study group of renal diseasesJ Gerstoft, J T Balsløv, M Brahm, et al.
Acta Medica Scandinavica|January 1, 1985
Prognosis in glomerulonephritis. A follow-up study of 395 consecutive, biopsy-verified cases. I. Classification, renal histology and outcome. Report from a Copenhagen study group of renal diseasesM Brahm, J T Balsløv, C Brun, et al.
Scandinavian Journal of Immunology|August 10, 2000
Effects of G-CSF on telomere lengths in PBMCs from human immunodeficiency virus-infected patients: results from a randomized, placebo-controlled trialH Aladdin, H Ullum, P Schjerling, et al.
AIDS (London, England)|November 1, 1990
Trends in survival of Danish AIDS patients from 1981 to 1989C Pedersen, J Gerstoft, P Tauris, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1989
Prognostic value of immunologic abnormalities and HIV antigenemia in asymptomatic HIV-infected individuals: proposal of immunologic stagingB Hofmann, I Bygbjerg, E Dickmeiss, et al.
HIV Medicine|August 9, 2011
Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV-infected individuals from 1995 to 2007: a nationwide cohort study*M V Larsen, Z B Harboe, S Ladelund, et al.
Scandinavian Journal of Immunology|September 6, 2000
The effect of long-term treatment with granulocyte colony-stimulating factor on hematopoiesis in HIV-infected individualsS D Nielsen, T U Sørensen, H Aladdin, et al.
European Journal of Clinical Investigation|August 1, 1984
T lymphocyte subsets in homosexual men from CopenhagenJ Gerstoft, C S Petersen, S Kroon, et al.
AIDS (London, England)|July 1, 1996
Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study GroupP Hermans, J Lundgren, B Sommereijns, et al.
Pageof 20